Pharma Mar SA (PHM) Stock Statistics & Valuation Metrics

Pharma Mar SA has a market cap or net worth of €1.77B. The enterprise value is €1.72B.

Pharma Mar SA has 18,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharma Mar SA’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is 12.83%.

The current PE Ratio of Pharma Mar SA is 245.3. Pharma Mar SA’s PEG ratio is 0.09.

In the last 12 months, Pharma Mar SA had revenue of 221.39M and earned 74.99M in profits. Earnings per share was 4.36.

In the last 12 months, operating cash flow was 68.00M and capital expenditures -10.22M, giving a free cash flow of 57.77M billion.

Pharma Mar SA pays an annual dividend of €0.8, resulting in a dividend yield of 1.04%

Pharma Mar SA upcoming earnings date is Aug 5, 2026, TBA (Confirmed).

Pharma Mar SA as a current ratio of 3.02, with Debt / Equity ratio of 19.04%

In the past 12 months, Pharma Mar SA has paid -15.34M in taxes.

Pharma Mar SA EV to EBITDA ratio is 27.34, with an EV/FCF ratio of 30.19.

Pharma Mar SA has €167.85M in cash and marketable securities with €47.54M in debt, giving a net cash position of €120.32M billion.

Gross margin is 92.66%, with operating margin of 18.19%, and net profit margin of 33.87%.

The average price target for Pharma Mar SA is €120.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy